Sam Tabone, Partner at XEIA joins Brom on the podcast to discuss XEIA's "Human 3" thesis.

Check out XEIA at https://www.xeiavp.com/

Timestamps

0:00 - why we created Human 3 - going from psychedelic medicine to the broader Human 3 space

8:00 - critiquing the Human 3 manifesto

12:00 regulatory and social drivers of Human 3

19:00 - what Human 3 is NOT

31:00 - what defines Human 3 / what Human 3 is?

50:00 - areas where Human 3 can make the biggest impact

58:00 - distribution shifting technologies 1:10:00 - how Human 3 is useful outside of Neuro

1:20:00 - closing thoughts

The Human 3 Manifesto:

Human 3: the new epoch of health, wellbeing and performance

While modern medicine (Human 2) benefited society in incalculable ways, it ultimately fell short of its promise because the available tools forced it to operate at an incremental pace with long feedback loops.Today, exponential technologies like AI - which can parse through terabytes of scientific literature and data in seconds - and brain-computer-interfaces, biosensors and CRISPR - which enable real-time, read-write access to our biology - promise to rapidly accelerate the scientific method flywheel and lead to an exponential explosion in health, wellness and performance.

Human 3 will elevate every area of health and wellbeing, but will have the biggest impact in areas where modern medicine has made the least progress: the mental health crisis, neurodegeneration, chronic disease and aging. These are the “focal points” of our investment strategy.

Human 3 is not a “sector” - our companies combine life sciences, AI, hardware, software, deep tech & health tech in novel ways that often defy conventional categorization. Human 3 is a philosophy of vitality. It is a knowing that the “user experience” of the human body and mind is long overdue for an upgrade. It is the willingness to build and invest in that future. This is Human 3.

This movement marks the third great epoch of human health:

• Human 1 was defined by medieval practices like bloodletting and humorism - medicine before evidence.

• Human 2 was the era of “modern” medicine, which began in the 1850s when Louis Pasteur popularized the germ theory of disease and the scientific method became the gold standard. Human 2 was constrained by both incremental tools and artificial boundaries between disciplines.

• Human 3 builds on Human 2’s legacy of scientific rigour, but is accelerated by exponential technologies, transdisciplinary collaborations, and driven by a belief that we can do so much more to not just heal the sick, but to prevent illness in the first place and elevate the already healthy.

‍‍‍

Marcus Capone is founder of TARA Mind. TARA Mind is an employee benefit provider that allows companies of all sizes to offer Ketamine therapy to their employees as a mental health benefit.Marcus is also the Chairman and Co-Founder of VETS: Veterans Exploring Treatment Solutions, VETS is a non profit that provides resources, research, and advocacy for U.S. Special Operations veterans seeking alternative mental health treatments. Marcus is a Veteran Navy SEAL, Marcus retired from active duty in 2013, after several tours at SEAL Teams 10 and 6.More on TARA Mind: https://www.taramind.com/

XEIA Venture Partners (Brom's VC fund) is an investor in TARA Mind: www.xeiavp.com

Amit Deshwar is the Founder & CTO of Kerna Labs. Backed by Gradient Ventures (Google's AI fund), Kerna Labs is building foundational AI models that aim to unlock the full potential of mRNA as the universal toolkit for genetic medicine. Kerna Labs' CSO is Melissa J. Moore, the former CSO of Moderna who helped lead the development of the Moderna COVID vaccine.

Brom Rector: https://x.com/therealbrom

Ramsay Brown, founder of Mission Control - a leading provider of AI agents / synthetic workers to the defense industry, joins us to discuss the end of the Anthropocene, what a world filled with synthetic labor looks like, Project Stargate, Trump and AI, why you need to be Rick Rubin and more.

Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics, AI, consciousness, why Marc Andreessen hates psychedelics, and the intersection of all these things.

Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain Stimulation minimally invasive though the development of nano fibers that are 10X thinner than traditional Deep Brain Stimulation leads - allowing them to be inserted endovascularly into the brain.

Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so.

www.kadencebio.com

Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still!

Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond.

This is a crossover episode from the Business Trip podcast.

Why Academics & PhDs Should Consider Starting a Startup - Fireside chat with Brom Rector and Sam Tabone at the USC Neuroscience Graduate Program Retreat

Will MDMA and psychedelic therapy be affordable?